Evista (raloxifene) can help prevent breast cancer in postmenopausal women with osteoporosis
February 2005
There's more evidence that Evista (raloxifene) can help prevent breast cancer in postmenopausal women with osteoporosis.
Evista is approved only to prevent or treat osteoporosis in postmenopausal women. But these women seem to have a 60% reduction in breast cancer while taking Evista.
But don't recommend Evista just to prevent breast cancer.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive